Original Article

Comparing COVID-19 Among Some Highly Affected States in the United States of America

Abstract

Introduction: Coronavirus disease 2019 (COVID-19), a respiratory disease caused by the coronavirus SARSCoV-2, has had an immense impact on a variety of sectors both worldwide and nationwide. Vast differences are observed among states within the United States of America in terms of COVID-19 cases and deaths.
Objective: The objective of this paper is to present a means through which we can compare deaths between multiple states, using the index date approach applied by Middelburg and Rosendaal.
Materials and Methods: Using the CDC COVID-19 tracker, we created two sets of ten states focusing on states with (1) the highest number of deaths and (2) the highest number of deaths per 100,000. We applied features of the authors’ technique in order to compare deaths between certain states through visualizations. We referred to the cumulative number of deaths on each day from January 21st, 2020 to September 30th, 2020, as a percentage of the cumulative deaths 40 days after the first death.
Results and Discussion: Comparability was established by synchronizing each state to a baseline date, which allows us to adjust for issues that arise from the scales used within a standard cumulative deaths graph, such as a tendency to be driven by the states with the highest cumulative number of deaths. This technique also normalized each state to a standard start date.
Conclusion: This paper shows the application of a technique that allows for clearer comparisons of COVID19 related deaths between states, as opposed to the use of a standard cumulative deaths graphs. 

1. COVID-19 Cases, Deaths, and Trends in the US | CDC COVID Data Tracker [Internet]. Centers for Disease Control and Prevention. 2020 [cited 11 November 2020]. Available from: https://covid.cdc.gov/covid-data- tracker/#cases_casesinlast7days
2. COVID-19 Guidance for Older Adults [Internet]. Centers for Disease Control and Prevention. 2020 [cited 11 November 2020]. Available from: https://www.cdc.gov/aging/covid19-guidance.html
3. Coronavirus Disease 2019 (COVID-19) [Internet]. Centers for Disease Control and Prevention. 2020 [cited 11 November 2020]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-race-ethnicity.html
4. Similarities and Differences between Flu and COVID-19 [Internet]. Centers for Disease Control and Prevention. 2020 [cited 11 November 2020]. Available from: https://www.cdc.gov/flu/symptoms/flu-vs-covid19.htm
5. Chen, C., Chen, C., Yan, J.T., Zhou, N., Zhao, J.P., & Wang, D.W. Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19. Zhonghua xin xue Guan Bing za zhi (obtained through Europe PMC). 2020; 48(7): 567-571.
6. Council of State and Territorial Epidemiologists. Interim-20-ID-01: Standardized surveillance case definition and national notification for 2019 novel coronavirus disease (COVID-19). 2020.
7. Fotuhi M, Mian A, Meysami S, Raji C. Neurobiology of COVID-19. Journal of Alzheimer's Disease. 2020; 76(1): 3-19.
8. Guzik, T. J., Mohiddin, S. A., Dimarco, A., Patel, V., Savvatis, K., Marelli-Berg, F. M., Madhur, M. S., Tomaszewski, M., Maffia, P., D'Acquisto, F., Nicklin, S. A., Marian, A. J., Nosalski, R., Murray, E. C., Guzik, B., Berry, C., Touyz, R. M., Kreutz, R., Wang, D. W., Bhella, D., Sagliocco, O., Crea, F., Thompson, E.C., & McInnes, I. B.. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovascular research. 2020; 116(10): 1666–1687.
9. Institute for Health Metrics and Evaluation (IHME) COVID-19 Forecasting Team & Hay, S.I. COVID-19 scenarios for the United States. MedRxiv. 2020.
10. COVID-19 Map - Johns Hopkins Coronavirus Resource Center [Internet]. Johns Hopkins Coronavirus Resource Center. 2020 [cited 11 November 2020]. Available from: https://coronavirus.jhu.edu/map.html
11. Khafaie M, Rahim F. Cross-Country Comparison of Case Fatality Rates of COVID-19/SARS-COV-2. Osong Public Health and Research Perspectives. 2020; 11(2): 74-80.
12. COVID-19 (coronavirus): Long-term effects [Internet]. Mayo Clinic. 2020 [cited 11 November 2020]. Available from:
https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/coronavirus-long-term-effects/art-20490351
13. Menter T, Haslbauer J, Nienhold R, Savic S, Hopfer H, Deigendesch N et al. Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020; 77(2): 198-209.
14. Middelburg, R.A. & Rosendaal, F.R. COVID-19: How to make between-country comparisons. International Journal of Infectious Diseases. 2020; 96: 477-481.
15. Nicola, M., Alsafi, Z., Sohrabi, C., Kerwan, A., Al-Jabir, A., Iosifidis, C., Agha, M., & Agha, R. The socio-economic implications of the coronavirus pandemic (COVID-19): A review. International journal of surgery (London, England). 2020; 78: 185–193.
16. Governor Ducey Announces Next Phase Of Arizona Recovery [Internet]. Office of the Arizona Governor. 2020 [cited 10 October 2020]. Available from: https://azgovernor.gov/governor/news/2020/05/governor-ducey-announces-next-phase-arizona-recovery
17. Gov. Kemp Signs New COVID-19 Executive Order [Internet]. Office of the Georgia Governor - Brian P. Kemp. 2020 [cited 10 October 2020]. Available from: https://gov.georgia.gov/press-releases/2020-06-11/gov-kemp-signs-new-covid-19-executive-order.
18. Pero, A., Ng, S., & Cai, D. COVID-19: A Perspective from Clinical Neurology and
Neuroscience. The Neuroscientist. 2020; 26(5–6): 387–391.
19. Pan, F., Ye, T., Sun, P., Gui, S., Liang, B., Li, L., Zheng, D., Wang, J., Hesketh, R. L., Yang, L., & Zheng, C. Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19). Radiology. 2020; 295(3): 715–721.
20. Puntmann V.O., Carerj M.L., Wieters I., Fahim, M., Arendt, C., Hoffmann, J, Shchendrygina, A., Escher, F., Vasa-Nicotera, M., Zeiher, A.M., Vehreschild, M., & Nagel, E. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020.
21. Singhal, A., Singh, P., Lall, B., Joshi, S. D. Modeling and prediction of COVID-19 pandemic using Gaussian mixture model. Chaos, Solitons & Fractals. 2020; 138.
22. The New York Times GitHub Repository. Data Source: nytimes/covid-19-data/us-states.csv. 2020 [cited 10 October 2020]. Available from https://github.com/nytimes/covid-19-data.
23. 2019 National and State Population Estimates. United States Census Bureau. 2019 [cited 10 October 2020]. Available from https://www.census.gov/newsroom/press-kits/2019/national-state-estimates.html.
24. Timeline of WHO’s response to COVID-19. World Health Organization. 2020 [cited 10 October 2020]. Available from: https://docs.google.com/document/d/1Gahg8DaecBl-eTlGjXWle337sDrVRBjfG-lfXF01b4M/edit#.
25. Yao H, Chen J, Xu Y. Patients with mental health disorders in the COVID-19 epidemic. The Lancet Psychiatry. 2020;7(4):e21.
Files
IssueVol 6 No 3 (2020) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/jbe.v6i3.5102
Keywords
COVID-19; Health; Pandemics; United States; Index Date
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Sabillon C, Guzman C, Kibria G. Comparing COVID-19 Among Some Highly Affected States in the United States of America. JBE. 2020;6(3):179-189.